Wells Fargo & Company initiated coverage on shares of CME Group (NASDAQ:CME – Free Report) in a research note released on Friday morning, Marketbeat.com reports. The brokerage issued an overweight rating and a $301.00 target price on the financial services provider’s stock.
CME has been the subject of several other research reports. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $316.00 to $323.00 in a report on Thursday, June 11th. Erste Group Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. Deutsche Bank Aktiengesellschaft lowered shares of CME Group from a “buy” rating to a “hold” rating and dropped their target price for the company from $286.00 to $270.00 in a research report on Wednesday, August 19th. Morgan Stanley boosted their price target on shares of CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research note on Thursday, July 23rd. Finally, Piper Sandler decreased their price target on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $289.81.
Check Out Our Latest Stock Report on CME
CME Group Price Performance
CME Group (NASDAQ:CME – Get Free Report) last announced its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the company earned $2.96 EPS. The company’s quarterly revenue was up .8% compared to the same quarter last year. On average, research analysts expect that CME Group will post 12.27 EPS for the current fiscal year.
CME Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Wednesday, September 9th were issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend was Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 44.11%.
Insider Buying and Selling
In related news, CEO Terrence Duffy sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $274.44, for a total value of $4,116,600.00. Following the completion of the sale, the chief executive officer owned 40,630 shares in the company, valued at $11,150,497.20. The trade was a 26.96% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director William Shepard purchased 293 shares of CME Group stock in a transaction on Friday, September 25th. The shares were acquired at an average price of $268.76 per share, for a total transaction of $78,746.68. Following the completion of the transaction, the director directly owned 263,289 shares of the company’s stock, valued at approximately $70,761,551.64. The trade was a 0.11% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.30% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On CME Group
Institutional investors and hedge funds have recently made changes to their positions in the business. First Citizens Financial Corp bought a new stake in CME Group in the 3rd quarter worth approximately $888,000. CX Institutional lifted its holdings in shares of CME Group by 137.1% during the 3rd quarter. CX Institutional now owns 5,354 shares of the financial services provider’s stock valued at $1,403,000 after buying an additional 3,096 shares during the period. Planning Strategies Inc. lifted its holdings in shares of CME Group by 1,528.6% during the 3rd quarter. Planning Strategies Inc. now owns 228 shares of the financial services provider’s stock valued at $60,000 after buying an additional 214 shares during the period. Burkett Financial Services LLC purchased a new position in shares of CME Group in the 3rd quarter worth $62,000. Finally, Envestnet Portfolio Solutions Inc. boosted its stake in shares of CME Group by 16.6% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 70,325 shares of the financial services provider’s stock worth $14,809,000 after buying an additional 10,005 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.
More CME Group News
Here are the key news stories impacting CME Group this week:
- Positive Sentiment: Record trading activity supports revenue prospects: CME Group reported September and third-quarter average daily volume records, with ADV rising 22% year over year in September and 16% for the quarter. Higher volumes generally increase clearing and transaction revenue. CME Group Sets September, Q3 Average Daily Volume Records
- Positive Sentiment: Strong soybean futures participation: CME Group set a new open-interest record in soybean futures, indicating continued engagement in agricultural derivatives and supporting the exchange’s diversified volume base. CME Group Sets New Open Interest Record in Soybean Futures
- Positive Sentiment: Third-quarter earnings expectations remain favorable: Analysts anticipate low double-digit bottom-line growth when CME Group reports third-quarter results later this month, helped by the elevated trading volumes. What You Need to Know Ahead of CME Group’s Earnings Release
- Neutral Sentiment: Investor commentary highlights a volume-versus-price disconnect: Cambiar Investors’ quarterly letter discussed CME Group as a potential addition on weakness, noting that record trading activity has not translated into comparable stock performance. This may attract value-oriented investors but also underscores market hesitation. CME Group Adding on Weakness
- Negative Sentiment: Valuation may limit near-term upside: An analysis asked whether CME Group is fully priced following its push into cryptocurrency futures, suggesting investors may need additional growth or execution evidence to justify further appreciation. Is CME Group Fully Priced After Its Crypto Futures Push?
- Negative Sentiment: Analyst rating adds pressure: Wall Street analysts recently assigned CME Group a “Hold” rating, reinforcing the view that the stock’s strong operating performance may already be reflected in its valuation. CME Group Stock Rated Hold
CME Group Company Profile
CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.
The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.
CME Group’s history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.
Recommended Stories
- Five stocks we like better than CME Group
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
